Immusoft gave a glimpse on Monday at how the first patient to ever receive an engineered B cell therapy is doing nine months ...

MeiraGTx unveiled results from a small dataset for its Parkinson’s disease gene therapy on Tuesday morning, causing its ...

Johnson & Johnson cut a handful of trials across its portfolio in the third quarter, including a Phase 2 study of a touted ...

Pfizer is deepening its investment in protein degraders through a new partnership with Triana Biomedicines, a startup working ...

Walgreens is closing 1,200 stores, or 14% of its locations, as it fights to turn around its business. The retail pharmacy ...

Stem cell biologist William Rust has been quietly working on a cure for diabetes for more than a decade. Later this year, ...

Tolerance Bio has launched with an oversubscribed $17.2 million seed round and a goal to develop therapies for ...

Protein production company Nuclera has raised a $75 million Series C to bring its manufacturing platform to market next ...

Dutch biotech investor Forbion has raised two new funds to put into biotech companies, just 18 months after its last major ...

Eli Lilly plans to invest £279 million ($364 million) in the UK as part of a new government partnership in which the ...

Novartis used one of its priority review vouchers (PRV) to speed the September approval of Kisqali in early breast cancer, ...

Private equity firms TPG and Blackstone are working on a potential deal to buy Brent Saunders-led eye care company Bausch + ...